Insiders · LCTX

LCTX insider transactions

Lineage Cell Therapeutics Inc. (LCTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LCTX

• 88d
  President and CEO Culley Brian M bought $24,375 worth of shares (15,000 units at $1.62), increasing direct ownership by 6% to 255,516 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 94d
  SEC Form 4 filed by President and CEO Culley Brian M

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 94d
  SEC Form 4 filed by Chief Financial Officer Howe Jill Ann

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 94d
  SEC Form 4 filed by General Counsel and Secretary Samuel George A. Iii

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 115d
  General Counsel and Secretary Samuel George A. Iii converted options into 6,075 shares and covered exercise/tax liability with 2,502 shares, increasing direct ownership by 13% to 31,063 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 115d
  President and CEO Culley Brian M converted options into 31,250 shares and covered exercise/tax liability with 12,869 shares, increasing direct ownership by 8% to 240,516 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 171d
  President and CEO Culley Brian M was granted 8,925 shares and covered exercise/tax liability with 334 shares, increasing direct ownership by 4% to 222,135 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 171d
  General Counsel and Secretary Samuel George A. Iii was granted 1,735 shares and covered exercise/tax liability with 65 shares, increasing direct ownership by 6% to 27,490 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 340d
  SEC Form 4 filed by Director Bradsher Neal C

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 341d
  SEC Form 4 filed by Director Amin Dipti

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 341d
  SEC Form 4 filed by Director Jayasuriya Anula

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 341d
  SEC Form 4 filed by Director Andrews Deborah J

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 341d
  SEC Form 4 filed by Director Mulroy Michael H.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 341d
  SEC Form 4 filed by Director Russell Angus C.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 453d
  SEC Form 4 filed by President and CEO Culley Brian M

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 453d
  SEC Form 4 filed by Chief Financial Officer Howe Jill Ann

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 453d
  SEC Form 4 filed by General Counsel and Secretary Samuel George A. Iii

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 481d
  General Counsel Samuel George A. Iii converted options into 6,076 shares and covered exercise/tax liability with 2,440 shares, increasing direct ownership by 16% to 25,820 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 481d
  President and CEO Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,547 shares, increasing direct ownership by 10% to 213,544 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 496d
  Director Broadwood Partners, L.P. bought $6,000,000 worth of shares (7,894,737 units at $0.76) (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 559d
  Chief Financial Officer Howe Jill Ann bought $8,850 worth of shares (15,000 units at $0.59), increasing direct ownership by 143% to 25,500 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 559d
  General Counsel Samuel George A. Iii bought $9,000 worth of shares (15,000 units at $0.60), increasing direct ownership by 209% to 22,184 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 560d
  Director Mulroy Michael H. bought $22,640 worth of shares (40,000 units at $0.57), increasing direct ownership by 15% to 298,555 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 563d
  President and CEO Culley Brian M bought $24,000 worth of shares (40,000 units at $0.60), increasing direct ownership by 26% to 194,842 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 658d
  Chief Financial Officer Howe Jill Ann bought $9,345 worth of shares (10,500 units at $0.89) (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Mulroy Michael H.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Russell Angus C.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Andrews Deborah J

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Jayasuriya Anula

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Bailey Don M

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Amin Dipti

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 705d
  SEC Form 4 filed by Director Bradsher Neal C

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 741d
  Culley Brian M bought $10,500 worth of shares (10,000 units at $1.05), increasing direct ownership by 7% to 154,842 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 822d
  SEC Form 4 filed by Samuel George A. Iii

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 822d
  SEC Form 4 filed by Culley Brian M

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 822d
  SEC Form 4 filed by Howe Jill Ann

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 847d
  Samuel George A. Iii covered exercise/tax liability with 2,490 shares and converted options into 6,076 shares, increasing direct ownership by 100% to 7,184 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 847d
  Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,806 shares, increasing direct ownership by 15% to 144,842 units (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 851d
  Bailey Don M bought $100,001 worth of shares (96,155 units at $1.04) (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 851d
  Broadwood Partners, L.P. bought $7,000,001 worth of shares (6,730,770 units at $1.04) (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 888d
  Jayasuriya Anula bought $10,900 worth of shares (10,000 units at $1.09) (SEC Form 4)

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Bailey Don M

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Mulroy Michael H.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Andrews Deborah J

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Russell Angus C.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Amin Dipti

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Kingsley Alfred D

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Jayasuriya Anula

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1071d
  SEC Form 4 filed by Bradsher Neal C

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1186d
  SEC Form 4 filed by Hogge Gary S.

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1186d
  SEC Form 4 filed by Samuel George A. Iii

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1186d
  SEC Form 4 filed by Culley Brian M

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1186d
  SEC Form 4 filed by Howe Jill Ann

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1210d
  SEC Form 5: Kingsley Alfred D gifted 25,000 shares, decreasing direct ownership by 0.46% to 5,430,545 units

  5 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1210d
  SEC Form 4: Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,744 shares, increasing direct ownership by 17% to 126,399 units to cover taxes

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1210d
  SEC Form 4: Samuel George A. Iii converted options into 6,076 shares and covered exercise/tax liability with 2,478 shares to satisfy withholding tax

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1210d
  SEC Form 4: Hogge Gary S. converted options into 13,020 shares and covered exercise/tax liability with 5,310 shares to satisfy tax liability

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1300d
  SEC Form 4 filed by Howe Jill Ann

  4 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1300d
  SEC Form 3 filed by new insider Howe Jill Ann

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1431d
  SEC Form 3 filed by new insider Hernandez Alexandra

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)